Back
Speaker illustration

Ms Eva Christine Ida Woelders

Radboud University Medical Centre, Nijmegen (Netherlands (The))

Member of:

European Society of Cardiology

Presentations

Complex versus non-complex, should we adjust the antiplatelet strategy to the type of percutaneous coronary intervention? Results from a real world PCI population

Event: ESC Congress 2024

Topic: Outcome

Session: The guardians of clotting: exploring antiplatelet strategies

Access
Like
Thumbnail

Undiagnosed Diabetes Mellitus is an important risk factor in secondary prevention after an acute coronary syndrome and warrants active screening

Event: ESC Congress 2024

Topic: Prevention

Session: Advancing cardiac care in acute coronary syndromes: from genetics to social determinants

Access
Like
Thumbnail

Lipid lowering treatment after percutaneous coronary intervention: data from the large contemporary ZON-HR registry.

Event: ESC Congress 2023

Topic: Primary Percutaneous Coronary Intervention (PCI)

Session: Beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon

Access
Like
Thumbnail

Parsimonious versus extensive score: can we simplify bleeding risk stratification after percutaneous coronary intervention without losing specificity?

Event: ESC Congress 2023

Topic: Outcome

Session: Renal failure and bleeding in PCI patients

Access
Like
Thumbnail

High bleeding risk mainly predicts non-access site bleeding events in the first month after percutaneous coronary intervention

Event: ESC Congress 2023

Topic: Outcome

Session: Renal failure and bleeding in PCI patients

Access
Like
Thumbnail

The effect of P2Y12 inhibitor monotherapy according to bleeding risk: a systematic review and meta-analysis

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Treatment of coronary artery disease

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources